A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

BACKGROUND: HIV-infected, treatment-experienced adults with a history of prior resistance and regimen failure can be virologically suppressed but may require multitablet regimens associated with lower adherence and potential resistance development. METHODS: We enrolled HIV-infected, virologically su...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Acquir Immune Defic Syndr
Egile Nagusiak: Huhn, Gregory D., Tebas, Pablo, Gallant, Joel, Wilkin, Timothy, Cheng, Andrew, Yan, Mingjin, Zhong, Lijie, Callebaut, Christian, Custodio, Joseph M., Fordyce, Marshall W., Das, Moupali, McCallister, Scott
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: JAIDS Journal of Acquired Immune Deficiency Syndromes 2017
Gaiak:
Clinical Science
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5228611/
https://ncbi.nlm.nih.gov/pubmed/27753684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001193
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak